← SearchDevelopment of Therapeutic Products for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases$185,160N01FY2024AINIHVenatorx Pharmaceuticals, Inc., Malvern PAInvestigatorsTimothy HenkelcontactView original record on NIH RePORTER →